<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Article Tag Suite 1.1//EN"
  "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink"
         xmlns:mml="http://www.w3.org/1998/Math/MathML"
         article-type="research-article"
         xml:lang="en">
  <front>
    <journal-meta>
      <journal-title-group>
        <journal-title>American Journal of PharmTech Research</journal-title>
        <abbrev-journal-title abbrev-type="publisher">AJPTR</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="epub">2249-3387</issn>
      <publisher>
        <publisher-name>undefined</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">AJPTR45006</article-id>
      <title-group>
        <article-title>Transdermal Drug Delivery System: an Overview</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Sudarshan</surname>
            <given-names>Upadhye Shashikant</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kothali</surname>
            <given-names>Bharateshwar Kallappa</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Apte</surname>
            <given-names>Aishwarya Kumar</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kulkarni</surname>
            <given-names>Anuja Aniruddha</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Khot</surname>
            <given-names>Vidyarani Sujitkumar</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Patil</surname>
            <given-names>Archana Abhaykumar</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
      </contrib-group>
      <aff id="aff1">Dr. J.J. Magdum Pharmacy College, Jaysingpur</aff>
      <pub-date pub-type="epub" iso-8601-date="2014-10-01">
        <month>10</month>
        <day>01</day>
        <year>2014</year>
      </pub-date>
      <volume>4</volume>
      <issue>5</issue>
      <abstract>
        <p>The drug delivery through the skin to achieve a systemic as well as local effect of a drug is known as Transdermal drug delivery system. Its main advantage includes controlled drug release with minimum side effects, improved bioavailability and many more. The human skin is readily accessible surface for drug delivery. For penetration of drug through the skin the stratum corneum is the main barrier. So to avoid the stratum corneum and to increase the flux through the skin membrane different techniques of penetration enhancement are used.  This review mainly represents different factors affecting Transdermal bioavailability, technologies for developing Transdermal drug delivery system, different evaluation tests for Transdermal patches, different methods of preparation of TDDS, recent techniques for enhancing Transdermal drug delivery system.</p>
      </abstract>
      <kwd-group kwd-group-type="author">
        <kwd>Transdermal drug delivery system [TDDS]</kwd>
        <kwd>Controlled release</kwd>
        <kwd>Enhancement technique.</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <!-- Full article body not available in metadata-only JATS export. See PDF/HTML galley. -->
  </body>
  <back/>
</article>
